Dr. Irena A. Tsui, MD

Dr. Tsui practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Tsui's NPI, 1306023973, was assigned on January 26, 2008. Dr. Tsui graduated from Perelman School of Medicine - Philadelphia in 2004. Dr. Tsui holds California license A103523.

Dr. Tsui's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Tsui's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Tsui is also affiliated with Ronald Reagan UCLA Medical Center. Dmand AI also links Dr. Tsui to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tsui practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Tsui's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Tsui is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Tsui's licenses on file in 3 states: California, New York and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, eyelid inflammation, glaucoma, inflammation of iris and laser destruction of retinal or choroid lesions among the conditions Dr. Tsui treats.

CMS data shows 6,451 Medicare services from Dr. Tsui across 10 procedure codes in 2024, for 588 Medicare patients. Medicare paid $646,887 for them.

CMS counts 588 Medicare patients who saw Dr. Tsui in 2024. The largest group is 65 to 74, with 221 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tsui's median patient age at 67, with 53% women.

In 2024, Dr. Tsui wrote 335 Medicare Part D claims for 89 patients. 58% of them were for generic drugs. CMS names the drug for 283 of them, across 10 drugs with 11 or more claims each, at $29,528 in total drug cost. In 2023, CMS named 228 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Tsui for performance year 2024, reported as part of a group. Dr. Tsui accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Tsui, published from 2015 to 2018. Dr. Tsui's most frequent co-authors are Kristina N. Adachi, MD, Rishi R. Doshi, MD and Stephanie Lina Gaw, MD, PhD.

Dmand AI links Dr. Tsui to 1 clinical trial. Conditions studied include Diabetic Retinopathy and Diabetic Angiopathies.

CMS Open Payments shows 59 general payments to Dr. Tsui from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Alimera Sciences, Inc. paid the most, $10,000.

Dr. Tsui graduated from Perelman School of Medicine - Philadelphia in 2004.

Dr. Tsui is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.